(Q44633043)

4 December 2017

title

HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease (English)

1 reference

4 December 2017

3

1 reference

4 December 2017

Roland B Walter

1

1 reference

4 December 2017

Dietmar Fuchs

series ordinal

2

1 reference

4 December 2017

Thomas R Walter

series ordinal

4

1 reference

4 December 2017

Walter H Reinhart

series ordinal

5

1 reference

4 December 2017

publication date

1 October 2003

1 reference

Clinical Chemistry and Laboratory Medicine

4 December 2017

published in

1 reference

4 December 2017

volume

41

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1314-1319

1 reference

Atherosclerosis — An Inflammatory Disease

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Neopterin as a marker for activated cell-mediated immunity: application in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

C-reactive protein, statins, and the primary prevention of atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Serum neopterin and complex stenosis morphology in patients with unstable angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Increased serum neopterin: a marker of coronary artery disease activity in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Biochemical epidemiology in community-based studies: practical lessons from a study of T-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.200

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.200

1 reference

4 December 2017

1 reference